Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

AAN 2023

22–27 April 2023 | Boston, MA

AAN 2023

22–27 April 2023 | Boston, MA
Understanding the global burden of dementia: challenges and opportunities 5:22
Understanding the global burden of dementia: challenges and opportunities
Monica Diaz • 2 May 2023
Impact of the COVID-19 pandemic on patients with dementia and PD and their caregivers in Peru 3:10
Impact of the COVID-19 pandemic on patients with dementia and PD and their caregivers in Peru
Monica Diaz • 2 May 2023
A novel cognitive assessment based on augmented reality and machine learning 2:35
A novel cognitive assessment based on augmented reality and machine learning
Antonella Chadha Santuccione • 18 Apr 2023
The Women’s Brain Project call to action for an inclusive research agenda in brain health 2:24
The Women’s Brain Project call to action for an inclusive research agenda in brain health
Antonella Chadha Santuccione • 18 Apr 2023
Digital biomarkers to revolutionize clinical trial conduction in Alzheimer’s disease 3:38
Digital biomarkers to revolutionize clinical trial conduction in Alzheimer’s disease
Antonella Chadha Santuccione • 18 Apr 2023
NE3107 properties and mode of action 1:36
NE3107 properties and mode of action
Joseph Michael Palumbo • 26 Apr 2023
Ongoing concerns regarding lecanemab: efficacy & adverse events 2:28
Ongoing concerns regarding lecanemab: efficacy & adverse events
Philip Tipton • 27 Apr 2023
Phase II study of NE3107 in degenerative dementias 4:07
Phase II study of NE3107 in degenerative dementias
Joseph Michael Palumbo • 26 Apr 2023
The future of focused ultrasound in AD 4:08
The future of focused ultrasound in AD
Philip Tipton • 27 Apr 2023
Blood-based biomarkers for AD diagnosis 2:49
Blood-based biomarkers for AD diagnosis
Philip Tipton • 27 Apr 2023
Use of DBS to treat Alzheimer’s disease 3:51
Use of DBS to treat Alzheimer’s disease
Philip Tipton • 27 Apr 2023
Updates on anti-amyloid monoclonal antibodies for AD in Phase III trials 3:49
Updates on anti-amyloid monoclonal antibodies for AD in Phase III trials
Philip Tipton • 27 Apr 2023
Use of AD blood-based biomarkers for trial enrolment 4:01
Use of AD blood-based biomarkers for trial enrolment
Philip Tipton • 27 Apr 2023
Expanding research into biomarkers for RPD differentiation 1:19
Expanding research into biomarkers for RPD differentiation
Philip Tipton • 27 Apr 2023
PMN310 anti-amyloid antibody preserves learning and memory in animal models 2:27
PMN310 anti-amyloid antibody preserves learning and memory in animal models
Johanne Kaplan • 30 Mar 2023
The content of VJDementia is intended for healthcare professionals